Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Indocyanine green - Stryker

X
Drug Profile

Indocyanine green - Stryker

Alternative Names: IC 2000; IC2000-SPY Fluorescence Imaging Systems; IC2000-SPY-PHI; Indocyanine Green (ICG) for Injection; SPY AGENT GREEN

Latest Information Update: 17 Apr 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Novadaq Technologies
  • Developer Stryker Corporation
  • Class 3-ring heterocyclic compounds; Diagnostic agents; Imaging agents; Indoles; Naphthalenes; Organic sulfur compounds; Small molecules
  • Mechanism of Action Diagnostic imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Unspecified
  • Phase III Breast cancer

Most Recent Events

  • 19 Feb 2024 Registered for Unspecified (Diagnosis) in Australia (IV)
  • 19 Feb 2024 Registered for Unspecified (Diagnosis) in Australia (Parenteral)
  • 28 Jul 2023 Leiden University Medical Center plans a phase II FOCUS GREEN trial for Colorectal cancer (Dignosis, Combination therapy, metastatic disease) in October 2023 (Intradermal, Injection) (NCT05965817)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top